| DAA250 |
WD repeat and SOCS box-containing 2 |
Molecular |
brain |
Human |
WSB2 |
5.0% Decrease Gene Expression Level |
|
| DAA251 |
WW domain containing transcription regulator 1 |
Molecular |
brain |
Human |
WWTR1 |
24.0% Increase Gene Expression Level |
|
| DAA252 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
Molecular |
brain |
Human |
YWHAZ |
10.0% Decrease Gene Expression Level |
|
| DAA1392 |
zinc finger and BTB domain containing 16 |
Molecular |
hippocampus |
Mouse |
Zbtb16 |
2.0% Increase Gene Expression Level |
|
| DAA26 |
zinc finger, CCHC domain containing 24 |
Molecular |
brain |
Human |
ZCCHC24 |
15.0% Increase Gene Expression Level |
|
| DAA255 |
zer-1 homolog (C. elegans) |
Molecular |
brain |
Human |
ZER1 |
16.0% Decrease Gene Expression Level |
|
| DAA1275 |
zinc finger protein 64 |
Molecular |
brain |
Mouse |
Zfp64 |
5.0% Increase Gene Expression Level |
|
| DAA1276 |
zinc finger protein 68 |
Molecular |
brain |
Mouse |
Zfp68 |
5.0% Increase Gene Expression Level |
|
| DAA253 |
zinc fingers and homeoboxes 2 |
Molecular |
brain |
Human |
ZHX2 |
20.0% Increase Gene Expression Level |
|
| DAA60 |
zinc finger, MIZ-type containing 2 |
Molecular |
brain |
Human |
ZMIZ2 |
17.0% Decrease Gene Expression Level |
|
| DAA232 |
zinc finger protein 280A |
Molecular |
brain |
Human |
ZNF280A |
10.0% Decrease Gene Expression Level |
|
| DAA254 |
zinc finger protein 507 |
Molecular |
brain |
Human |
ZNF507 |
43.0% Increase Gene Expression Level |
|
| DAA758 |
Mild cognitive impairment incidence increases |
Psychological |
brain |
Human |
— |
— |
|
| DAA615 |
Alzheimer's disease |
Pathological |
brain |
Human |
— |
SeriesMorbidity |
|
| DAA1050 |
Mental Health (psychological distress) (Male) |
Pathological |
brain |
Human |
— |
SeriesIncidence |
|
| DAA748 |
Altered sleep parameters and patterns |
Psychological |
brain |
Human |
— |
— |
|
| DAA1051 |
Mental Health (psychological distress) (Female) |
Pathological |
brain |
Human |
— |
SeriesIncidence |
|
| DAA754 |
Memory impairment |
Psychological |
brain |
Human |
— |
— |
|
| DAA780 |
Medial temporal activation during encoding and retrieval of memory is reduced |
Physiological |
brain |
Human |
— |
— |
|
| DAA731 |
Mean diffusivity increases and water diffusion anisotropy decreases |
Physiological |
corpus callosum, white matter |
Human |
— |
— |
|
| DAA731 |
Mean diffusivity increases and water diffusion anisotropy decreases |
Physiological |
corpus callosum, white matter |
Human |
— |
— |
|
| DAA732 |
Glial cell number |
Physiological |
cerebral cortex |
Human |
— |
— |
|
| DAA2031 |
Altered concentration of sodium, potassium and calcium |
Physiological |
lens |
Human |
— |
— |
|
| DAA2041 |
Altered brain mitochondrial metabolism |
Physiological |
brain |
Human |
— |
— |
|
| DAA2033 |
Alterations in structural proteins and cell membranes in the lenses |
Physiological |
lens |
Human |
— |
— |
|